Fig. 1 · Structure
Documents & Downloads
Fetrastobart
ADC Antibody
Fetrastobart is a PD-L1 targeting antibody designed for use in antibody-drug conjugate (ADC) synthesis. This reagent selectively binds to the PD-L1 antigen, facilitating targeted delivery of cytotoxic agents to tumor cells expressing PD-L1, thereby enhancing therapeutic efficacy. Fetrastobart is suitable for research applications in oncology and immunotherapy, contributing to the development of novel ADCs for cancer treatment.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 3028439-63-3 |
| Applications | ADC Antibody |
| Molecular Weight | 144.90 kDa |
| Synonyms | SGN-PDL1V Antibody; PF-08046054 Antibody |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.